Latest ArticlesEN-USSun, 02 Aug 2015 18:24:41 -0400493215http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ea4cWZMm9Y4/obesity-statistics-take-a-wrong-turn-in-this-latest-study-cm493215
Obesity Statistics Take a Wrong Turn in This Latest StudySource Flickr user Next Twentyeight. Cancer is arguably the disease that garners the most global attention due to the swiftness with which it can kill, but in terms of sheer numbers<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Ea4cWZMm9Y4" height="1" width="1" alt=""/>Sun, 05 Jul 2015 19:24:54 Z2015-07-05T19:24:54Zhttp://www.nasdaq.com/article/obesity-statistics-take-a-wrong-turn-in-this-latest-study-cm493215486515http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ALL5j_hY52M/can-the-uptrend-continue-for-zafgen-zfgn-tale-of-the-tape-cm486515
Can the Uptrend Continue for Zafgen (ZFGN)? - Tale of the TapeInvestors certainly have to be happy with Zafgen Inc ( ZFGN ) and its short term performance. After all, the stock has jumped by 13.1% in the past 4 weeks, and it is also above its 20 Day Simple<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/ALL5j_hY52M" height="1" width="1" alt=""/>Fri, 12 Jun 2015 16:25:42 Z2015-06-12T16:25:42Zhttp://www.nasdaq.com/article/can-the-uptrend-continue-for-zafgen-zfgn-tale-of-the-tape-cm486515481196http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VFhIgYfmHq4/health-care-sector-update-for-05282015-kpti-atrs-zfgn-cm481196
Health Care Sector Update for 05/28/2015: KPTI, ATRS, ZFGNTop Health care stocks JNJ 0.1% PFE 0.2% ABT flat MRK flat AMGN 0.7% Health care shares were mainly lower in pre market trade Thursday. In health care stocks news, Karyopharm Therapeutics ( KPTI ) said Thursday it has<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/VFhIgYfmHq4" height="1" width="1" alt=""/>Thu, 28 May 2015 13:16:04 Z2015-05-28T13:16:04Zhttp://www.nasdaq.com/article/health-care-sector-update-for-05282015-kpti-atrs-zfgn-cm481196476408http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eF9t20sMx4o/obesity-biotech-gelesis-does-not-float-shares-52-million-ipo-postponed-cm476408
Obesity biotech Gelesis does not float shares; $52 million IPO postponedGelesis, which is developing a weight loss capsule for patients with obesity and type 2 diabetes, postponed its IPO on Wednesday. The Boston, MA based company was founded in 2006 and had planned to list on the NASDAQ under<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/eF9t20sMx4o" height="1" width="1" alt=""/>Wed, 13 May 2015 14:54:47 Z2015-05-13T14:54:47Zhttp://www.nasdaq.com/article/obesity-biotech-gelesis-does-not-float-shares-52-million-ipo-postponed-cm476408475307http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FMdCBhFlKBQ/should-you-buy-zafgen-zfgn-ahead-of-earnings-tale-of-the-tape-cm475307
Should You Buy Zafgen (ZFGN) Ahead of Earnings? - Tale of the TapeInvestors are always looking for stocks that are poised to beat at earnings season and Zafgen, Inc. ( ZFGN ) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/FMdCBhFlKBQ" height="1" width="1" alt=""/>Mon, 11 May 2015 16:23:33 Z2015-05-11T16:23:33Zhttp://www.nasdaq.com/article/should-you-buy-zafgen-zfgn-ahead-of-earnings-tale-of-the-tape-cm47530720150510-00038 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sS-PZqhxaTU/nvro-gets-fda-nod-zfgns-obesity-drug-proves-its-worth-hrtx-awaits-magic-20150510-00038
NVRO Gets FDA Nod, ZFGN's Obesity Drug Proves Its Worth, HRTX Awaits MAGICNVRO Gets FDA Nod, ZFGN's Obesity Drug Proves Its Worth, HRTX Awaits MAGIC<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/sS-PZqhxaTU" height="1" width="1" alt=""/>Sun, 10 May 2015 21:23:00 Z2015-05-10T21:23:00Zhttp://www.nasdaq.com/article/nvro-gets-fda-nod-zfgns-obesity-drug-proves-its-worth-hrtx-awaits-magic-20150510-00038474911http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DDoBVEGGFyg/will-juno-therapeutics-juno-miss-on-1q-earnings-again-analyst-blog-cm474911
Will Juno Therapeutics (JUNO) Miss on 1Q Earnings Again? - Analyst BlogJuno Therapeutics Inc.JUNO will be reporting first quarter 2015 results on May 11. Juno, which started trading from Dec 2014, posted a negative earnings surprise of 424.24% in the fourth quarter of 2014. Let's see how things are shaping<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/DDoBVEGGFyg" height="1" width="1" alt=""/>Sat, 09 May 2015 11:20:17 Z2015-05-09T11:20:17Zhttp://www.nasdaq.com/article/will-juno-therapeutics-juno-miss-on-1q-earnings-again-analyst-blog-cm474911474457http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iu1-VoA5cG0/will-actavis-act-earnings-streak-continue-in-1q-analyst-blog-cm474457
Will Actavis&#39; (ACT) Earnings Streak Continue in 1Q? - Analyst BlogActavisACT is scheduled to report first quarter 2015 results before the opening bell on May 11. Actavis has had a strong run in 2014 with an average beat of 3.87%. We expect the company to beat expectations in the<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/iu1-VoA5cG0" height="1" width="1" alt=""/>Thu, 07 May 2015 22:18:13 Z2015-05-07T22:18:13Zhttp://www.nasdaq.com/article/will-actavis-act-earnings-streak-continue-in-1q-analyst-blog-cm474457467502http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gly5CEcN3ro/3-bursting-biotech-stocks-1-to-buy-cm467502
3 Bursting Biotech Stocks -- 1 To BuyThe biotech industry is notorious for its pop and drop nature, but it also offers opportunities for risk tolerant investors. For instance, these three companies' stock prices have tumbled, and one could be worth buying.<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/gly5CEcN3ro" height="1" width="1" alt=""/>Tue, 21 Apr 2015 16:23:49 Z2015-04-21T16:23:49Zhttp://www.nasdaq.com/article/3-bursting-biotech-stocks-1-to-buy-cm467502464480http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/izXs8KY-SHc/the-best-stock-to-invest-in-obesity-drugs-cm464480
The Best Stock to Invest in Obesity DrugsConsidering the limited number of obesity drugs, it seems easiest to pick the best stock in the field by process of elimination. Company Drug FDA Approved? Roche Xenical Yes<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/izXs8KY-SHc" height="1" width="1" alt=""/>Sun, 12 Apr 2015 19:10:08 Z2015-04-12T19:10:08Zhttp://www.nasdaq.com/article/the-best-stock-to-invest-in-obesity-drugs-cm464480461413http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zvYYPks9MyU/the-latest-weight-loss-capsule-gelesis-files-for-a-60-million-ipo-cm461413
The latest weight loss capsule: Gelesis files for a $60 million IPOGelesis, which is developing a weight loss capsule for patients with obesity and type 2 diabetes, filed on Wednesday with the SEC to raise up to $60 million in an initial public offering. The company's lead candidate uses its<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/zvYYPks9MyU" height="1" width="1" alt=""/>Thu, 02 Apr 2015 12:22:43 Z2015-04-02T12:22:43Zhttp://www.nasdaq.com/article/the-latest-weight-loss-capsule-gelesis-files-for-a-60-million-ipo-cm461413458542http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BaMFG3nPIGk/zafgen-zfgn-crumbles-stock-falls-by-79-tale-of-the-tape-cm458542
Zafgen (ZFGN) Crumbles: Stock Falls by 7.9% - Tale of the TapeZafgen, Inc. ( ZFGN ) saw a big move last session, as the company's shares fell by 8% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/BaMFG3nPIGk" height="1" width="1" alt=""/>Wed, 25 Mar 2015 21:11:08 Z2015-03-25T21:11:08Zhttp://www.nasdaq.com/article/zafgen-zfgn-crumbles-stock-falls-by-79-tale-of-the-tape-cm458542439079http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X-cRWXYKTgw/despite-the-cdcs-best-efforts-this-disease-just-hit-record-levels-cm439079
Despite the CDC&#39;s Best Efforts, This Disease Just Hit Record LevelsSource Flickr user Next TwentyEight. Although cancer and heart disease may garner a significant portion of researchers' attention, obesity is a growing problem . According to estimates from the Centers for Disease<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/X-cRWXYKTgw" height="1" width="1" alt=""/>Mon, 02 Feb 2015 15:34:35 Z2015-02-02T15:34:35Zhttp://www.nasdaq.com/article/despite-the-cdcs-best-efforts-this-disease-just-hit-record-levels-cm439079433745http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rlFdCfZR224/forget-pills-could-this-device-put-an-end-to-obesity-in-america-cm433745
Forget Pills! Could This Device Put an End to Obesity in America?Source Behavorial Risk Factor Surveillance Systems, Centers for Disease Control and Prevention. Obesity might be sometimes overlooked as a disease that needs immediate attention, but the reality is it's a serious condition that<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/rlFdCfZR224" height="1" width="1" alt=""/>Sat, 17 Jan 2015 13:42:17 Z2015-01-17T13:42:17Zhttp://www.nasdaq.com/article/forget-pills-could-this-device-put-an-end-to-obesity-in-america-cm433745433117http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/crowyxr24fE/zafgen-zfgn-enters-overbought-territory-tale-of-the-tape-cm433117
Zafgen (ZFGN) Enters Overbought Territory - Tale of the TapeZafgen, Inc. ( ZFGN ) has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because ZFGN is now in overbought territory with an RSI value of 75.73.What is<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/crowyxr24fE" height="1" width="1" alt=""/>Thu, 15 Jan 2015 17:55:11 Z2015-01-15T17:55:11Zhttp://www.nasdaq.com/article/zafgen-zfgn-enters-overbought-territory-tale-of-the-tape-cm433117426701http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4eI5VkluGog/will-zafgen-zfgn-continue-to-surge-higher-tale-of-the-tape-cm426701
Will Zafgen (ZFGN) Continue to Surge Higher? - Tale of the TapeInvestors certainly have to be happy with Zafgen Inc ( ZFGN ) and its short term performance. After all, the stock has jumped by 33.8% in the past 4 weeks, and it is also above its 20 Day Simple<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/4eI5VkluGog" height="1" width="1" alt=""/>Wed, 24 Dec 2014 15:56:55 Z2014-12-24T15:56:55Zhttp://www.nasdaq.com/article/will-zafgen-zfgn-continue-to-surge-higher-tale-of-the-tape-cm426701